Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Maurizio Zangari

Concepts (496)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
150
2025
3050
9.970
 Why?
Thalidomide
33
2016
378
2.900
 Why?
Boronic Acids
17
2013
183
2.740
 Why?
Pyrazines
17
2013
190
2.730
 Why?
Bone Marrow
17
2022
363
1.840
 Why?
Hematopoietic Stem Cell Transplantation
21
2024
606
1.790
 Why?
Venous Thrombosis
8
2009
90
1.650
 Why?
Antineoplastic Combined Chemotherapy Protocols
31
2024
1031
1.620
 Why?
Paraproteinemias
7
2022
74
1.550
 Why?
Angiogenesis Inhibitors
12
2009
184
1.490
 Why?
Humans
164
2025
52593
1.340
 Why?
Protease Inhibitors
7
2011
59
1.300
 Why?
Chromosomes, Human, Pair 1
7
2023
96
1.270
 Why?
Proteasome Inhibitors
6
2016
105
1.220
 Why?
Prognosis
42
2025
2118
1.220
 Why?
Middle Aged
69
2025
13096
1.170
 Why?
Aged
66
2025
10191
1.160
 Why?
Neoplasm, Residual
7
2025
173
1.140
 Why?
Antibodies, Bispecific
6
2025
94
1.140
 Why?
Antineoplastic Agents
20
2024
1221
1.130
 Why?
Alkaline Phosphatase
7
2020
93
1.120
 Why?
Transplantation, Autologous
29
2024
488
1.020
 Why?
Thrombosis
6
2013
262
1.010
 Why?
Bone Remodeling
3
2016
154
1.000
 Why?
Bone Diseases
2
2021
95
0.990
 Why?
Monoclonal Gammopathy of Undetermined Significance
9
2025
125
0.950
 Why?
Male
76
2025
26863
0.930
 Why?
Female
75
2025
28262
0.910
 Why?
Osteogenesis
4
2018
366
0.900
 Why?
Gene Expression Profiling
22
2025
1110
0.870
 Why?
Immunologic Factors
5
2016
117
0.870
 Why?
Anticoagulants
6
2009
279
0.800
 Why?
Peripheral Blood Stem Cell Transplantation
6
2012
59
0.790
 Why?
Melphalan
12
2016
181
0.780
 Why?
Neoplasms, Plasma Cell
4
2024
37
0.780
 Why?
Activated Protein C Resistance
4
2011
10
0.760
 Why?
Adult
44
2025
14170
0.720
 Why?
Parathyroid Hormone
4
2018
151
0.720
 Why?
Venous Thromboembolism
3
2011
76
0.710
 Why?
Antibodies, Monoclonal
4
2022
478
0.700
 Why?
Durapatite
1
2020
23
0.670
 Why?
Plasma Cells
10
2025
239
0.670
 Why?
B-Cell Maturation Antigen
7
2025
98
0.670
 Why?
Disease-Free Survival
21
2019
464
0.650
 Why?
Gene Amplification
1
2019
58
0.640
 Why?
Thromboembolism
3
2009
51
0.640
 Why?
Aged, 80 and over
22
2025
3420
0.640
 Why?
Survival Rate
21
2020
952
0.640
 Why?
Neoplasm Proteins
7
2020
328
0.630
 Why?
Dexamethasone
14
2024
440
0.630
 Why?
Myeloablative Agonists
4
2012
32
0.620
 Why?
Retrospective Studies
25
2025
6671
0.610
 Why?
Disease Progression
17
2025
873
0.590
 Why?
Gene Expression Regulation, Neoplastic
12
2021
857
0.590
 Why?
Factor V
4
2011
11
0.580
 Why?
Oligopeptides
3
2018
92
0.580
 Why?
Bone and Bones
4
2021
494
0.580
 Why?
Spinal Fractures
1
2018
38
0.580
 Why?
Thymus Gland
1
2018
41
0.570
 Why?
Parathyroidectomy
1
2018
46
0.560
 Why?
Thyroidectomy
1
2018
61
0.560
 Why?
Translocation, Genetic
8
2021
265
0.550
 Why?
Clinical Trials as Topic
9
2022
472
0.550
 Why?
Chromosome Aberrations
11
2023
297
0.540
 Why?
Treatment Outcome
31
2022
5486
0.530
 Why?
Survival Analysis
14
2024
673
0.530
 Why?
Calcification, Physiologic
1
2017
42
0.530
 Why?
Follow-Up Studies
22
2024
2291
0.520
 Why?
Pelvis
1
2017
67
0.520
 Why?
Risk Factors
23
2024
3952
0.520
 Why?
Stem Cell Transplantation
11
2023
187
0.520
 Why?
Osteoblasts
6
2020
475
0.510
 Why?
Thrombophilia
4
2009
19
0.500
 Why?
Tumor Microenvironment
5
2024
255
0.480
 Why?
Chromosome Deletion
6
2023
141
0.470
 Why?
Drug Resistance, Neoplasm
7
2015
327
0.460
 Why?
Animals
19
2024
13507
0.450
 Why?
Neoplasms
3
2009
1308
0.450
 Why?
Transplantation Conditioning
7
2019
93
0.440
 Why?
Receptor, Parathyroid Hormone, Type 1
1
2013
25
0.420
 Why?
Neoplasm Recurrence, Local
7
2024
643
0.420
 Why?
Polycythemia Vera
1
2013
6
0.410
 Why?
Positron-Emission Tomography
4
2025
303
0.410
 Why?
Hemostasis
3
2008
61
0.400
 Why?
Neovascularization, Pathologic
4
2009
158
0.400
 Why?
Diffusion Magnetic Resonance Imaging
3
2025
133
0.400
 Why?
Mutation
6
2022
1344
0.390
 Why?
Combined Modality Therapy
17
2024
639
0.380
 Why?
Neutropenia
2
2023
115
0.380
 Why?
Hematopoietic Stem Cells
2
2012
188
0.350
 Why?
Bone Neoplasms
2
2010
184
0.350
 Why?
Evolution, Molecular
2
2021
95
0.340
 Why?
Amyloidosis
3
2009
85
0.340
 Why?
Doxorubicin
7
2009
241
0.340
 Why?
Immunotherapy, Adoptive
4
2024
167
0.320
 Why?
Mice
11
2024
5958
0.310
 Why?
Anti-Anxiety Agents
1
2009
35
0.310
 Why?
In Situ Hybridization, Fluorescence
7
2023
263
0.310
 Why?
Kaplan-Meier Estimate
10
2019
485
0.310
 Why?
Hemorrhagic Disorders
1
2009
6
0.310
 Why?
Cryoglobulinemia
1
2008
13
0.300
 Why?
Pain
2
2009
362
0.300
 Why?
Biopsy, Needle
1
2009
182
0.300
 Why?
Analgesics
1
2009
106
0.290
 Why?
Pulmonary Embolism
1
2009
85
0.290
 Why?
Recurrence
11
2024
683
0.290
 Why?
Collagen
2
2020
213
0.290
 Why?
Risk Assessment
7
2023
1350
0.280
 Why?
Hematologic Neoplasms
2
2022
106
0.270
 Why?
Cell Line, Tumor
4
2023
1436
0.270
 Why?
Farnesyltranstransferase
1
2006
4
0.270
 Why?
Vascular Endothelial Growth Factor Receptor-2
2
2004
38
0.270
 Why?
Osteolysis
2
2022
75
0.260
 Why?
Waldenstrom Macroglobulinemia
2
2022
40
0.260
 Why?
Pyrroles
2
2004
72
0.260
 Why?
Risk
4
2014
313
0.260
 Why?
Neoplasms, Second Primary
2
2024
77
0.260
 Why?
Cell Differentiation
4
2022
673
0.260
 Why?
Cell Proliferation
8
2023
1029
0.250
 Why?
Time Factors
11
2021
3000
0.250
 Why?
Sirolimus
1
2006
72
0.250
 Why?
Logistic Models
5
2018
934
0.250
 Why?
Signal Transduction
6
2021
1714
0.250
 Why?
Chromosomes, Human, Pair 17
2
2017
35
0.240
 Why?
Fluorodeoxyglucose F18
4
2021
188
0.230
 Why?
Plasmacytoma
2
2020
43
0.230
 Why?
Immunoglobulins, Intravenous
1
2025
63
0.220
 Why?
Enoxaparin
1
2004
31
0.220
 Why?
Polycomb Repressive Complex 2
2
2021
48
0.220
 Why?
Remission Induction
10
2021
219
0.220
 Why?
Indoles
2
2004
277
0.220
 Why?
Vascular Endothelial Growth Factor A
2
2004
187
0.210
 Why?
Prospective Studies
9
2019
2457
0.200
 Why?
Blood Coagulation
1
2003
62
0.200
 Why?
Bone Resorption
2
2022
302
0.200
 Why?
Proto-Oncogene Proteins B-raf
2
2020
80
0.190
 Why?
Hematopoietic Stem Cell Mobilization
3
2008
60
0.190
 Why?
Immunoglobulin Light Chains
2
2017
90
0.190
 Why?
Immunoconjugates
1
2022
37
0.190
 Why?
Randomized Controlled Trials as Topic
3
2012
600
0.190
 Why?
Drug Approval
1
2022
43
0.190
 Why?
Cell Cycle
2
2021
240
0.190
 Why?
Hemorrhage
3
2009
224
0.190
 Why?
Lymphoma, B-Cell
1
2022
62
0.180
 Why?
Chromosomal Instability
2
2019
16
0.180
 Why?
Epigenomics
1
2021
75
0.180
 Why?
Patient Participation
1
2022
69
0.180
 Why?
Chromosomes, Human, Pair 13
5
2008
38
0.180
 Why?
SOXC Transcription Factors
1
2021
13
0.180
 Why?
T-Lymphocytes
4
2024
329
0.180
 Why?
Arkansas
5
2021
2029
0.180
 Why?
Calcium Phosphates
1
2020
5
0.170
 Why?
Odontoblasts
1
2020
4
0.170
 Why?
HL-60 Cells
1
2020
19
0.170
 Why?
U937 Cells
1
2020
15
0.170
 Why?
Etoposide
5
2009
71
0.170
 Why?
K562 Cells
1
2020
41
0.170
 Why?
Genes, Tumor Suppressor
2
2021
73
0.170
 Why?
NIH 3T3 Cells
1
2020
52
0.170
 Why?
MCF-7 Cells
1
2020
62
0.170
 Why?
Mammals
1
2020
60
0.170
 Why?
Kidney Diseases
2
2020
231
0.170
 Why?
Practice Guidelines as Topic
1
2023
496
0.170
 Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.160
 Why?
Leukemia, Plasma Cell
1
2020
33
0.160
 Why?
Protein C
2
2011
20
0.160
 Why?
Myelodysplastic Syndromes
3
2007
86
0.160
 Why?
beta 2-Microglobulin
5
2008
39
0.160
 Why?
HEK293 Cells
1
2020
232
0.160
 Why?
Busulfan
1
2019
17
0.160
 Why?
Cisplatin
6
2009
285
0.160
 Why?
HeLa Cells
1
2020
261
0.160
 Why?
Gene Regulatory Networks
1
2020
111
0.160
 Why?
Hematopoiesis, Extramedullary
1
2019
9
0.160
 Why?
Atrial Fibrillation
1
2022
201
0.160
 Why?
Imaging, Three-Dimensional
2
2017
151
0.150
 Why?
Epigenesis, Genetic
2
2020
407
0.150
 Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.150
 Why?
Genome-Wide Association Study
1
2020
187
0.150
 Why?
Fractures, Compression
1
2018
17
0.150
 Why?
Healthcare Disparities
1
2022
300
0.150
 Why?
Predictive Value of Tests
4
2009
952
0.150
 Why?
Spleen
1
2019
171
0.150
 Why?
Genomic Instability
2
2016
89
0.150
 Why?
Fibrinolysis
2
2009
6
0.140
 Why?
Phosphotransferases
1
2018
17
0.140
 Why?
Blood Coagulation Factors
2
2009
18
0.140
 Why?
Cytokines
3
2007
626
0.140
 Why?
Antineoplastic Agents, Alkylating
6
2008
77
0.140
 Why?
Bacteremia
1
2019
90
0.140
 Why?
Adipocytes
1
2018
130
0.140
 Why?
Cell Line
1
2020
1033
0.140
 Why?
Gene Rearrangement
1
2018
76
0.140
 Why?
Cluster Analysis
4
2012
233
0.140
 Why?
Hexokinase
1
2017
16
0.140
 Why?
Metaphase
4
2016
46
0.140
 Why?
Heparin, Low-Molecular-Weight
2
2007
23
0.140
 Why?
Ultrasonography, Doppler
2
2007
42
0.130
 Why?
Renal Insufficiency
4
2010
115
0.130
 Why?
Calcium
1
2018
374
0.130
 Why?
Fibrinolytic Agents
2
2007
131
0.130
 Why?
Clonal Evolution
1
2016
59
0.130
 Why?
Gene Expression Regulation, Enzymologic
1
2017
181
0.120
 Why?
Tumor Burden
3
2020
136
0.120
 Why?
Gene Expression
1
2018
623
0.120
 Why?
Disease Models, Animal
4
2016
1486
0.120
 Why?
Bone Marrow Transplantation
4
2022
113
0.120
 Why?
Multivariate Analysis
7
2021
602
0.120
 Why?
Immunotherapy
2
2016
244
0.120
 Why?
Tumor Suppressor Protein p53
1
2017
224
0.120
 Why?
Genes, Neoplasm
1
2015
31
0.120
 Why?
Polymorphism, Single Nucleotide
2
2020
506
0.120
 Why?
Gene Dosage
1
2015
78
0.120
 Why?
Salvage Therapy
6
2006
136
0.120
 Why?
Incidence
2
2009
1077
0.120
 Why?
Algorithms
1
2018
668
0.110
 Why?
Transcriptome
3
2025
368
0.110
 Why?
Osteoclasts
3
2022
428
0.110
 Why?
Cystatin M
2
2024
19
0.100
 Why?
Altitude
1
2013
16
0.100
 Why?
Case-Control Studies
4
2011
1202
0.100
 Why?
Janus Kinase 2
1
2013
26
0.100
 Why?
Chromosomes, Human, Pair 11
3
2020
55
0.100
 Why?
Tomography, X-Ray Computed
2
2017
1162
0.100
 Why?
Cross-Sectional Studies
3
2023
1686
0.100
 Why?
STAT3 Transcription Factor
2
2010
87
0.100
 Why?
Models, Biological
1
2016
741
0.100
 Why?
Bone Density Conservation Agents
2
2010
75
0.100
 Why?
Protein-Tyrosine Kinases
3
2018
89
0.100
 Why?
Cytogenetic Analysis
6
2014
80
0.100
 Why?
Mice, Inbred C57BL
1
2018
1900
0.100
 Why?
Creatinine
2
2010
159
0.100
 Why?
Viremia
1
2012
23
0.100
 Why?
Clone Cells
2
2023
76
0.100
 Why?
Cytomegalovirus Infections
1
2012
36
0.090
 Why?
Models, Genetic
2
2016
172
0.090
 Why?
Clinical Trials, Phase II as Topic
1
2012
47
0.090
 Why?
Clinical Trials, Phase III as Topic
1
2012
48
0.090
 Why?
Viper Venoms
1
2011
6
0.090
 Why?
Drug Evaluation, Preclinical
1
2012
142
0.090
 Why?
Epidemiologic Methods
2
2008
46
0.090
 Why?
NF-kappa B
2
2018
329
0.090
 Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
6
0.090
 Why?
Arsenicals
1
2010
15
0.090
 Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
20
0.090
 Why?
Oxides
1
2010
21
0.090
 Why?
Mutation Rate
2
2021
36
0.090
 Why?
Granulocyte Colony-Stimulating Factor
2
2008
64
0.090
 Why?
Hypercalcemia
1
2010
34
0.090
 Why?
Transplantation, Homologous
4
2003
151
0.080
 Why?
Cyclophosphamide
4
2003
172
0.080
 Why?
Janus Kinase 1
1
2010
16
0.080
 Why?
Antineoplastic Agents, Hormonal
2
2007
53
0.080
 Why?
Anemia
1
2010
74
0.080
 Why?
MAP Kinase Kinase 1
1
2010
23
0.080
 Why?
Cyclin-Dependent Kinases
1
2010
26
0.080
 Why?
Proteinuria
1
2010
41
0.080
 Why?
Administration, Oral
2
2009
455
0.080
 Why?
Genomics
2
2023
270
0.080
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
83
0.080
 Why?
Alleles
2
2021
278
0.080
 Why?
Diphosphonates
1
2010
92
0.080
 Why?
Lorazepam
1
2009
13
0.080
 Why?
Dose-Response Relationship, Drug
3
2008
1378
0.080
 Why?
Receptors, Retinoic Acid
1
2009
22
0.080
 Why?
Hyperhomocysteinemia
1
2009
29
0.080
 Why?
Oxycodone
1
2009
26
0.080
 Why?
Anesthesia, Local
1
2009
17
0.080
 Why?
Prednisone
1
2009
102
0.080
 Why?
Histones
2
2021
316
0.080
 Why?
Tretinoin
1
2009
53
0.080
 Why?
Hemostatic Techniques
1
2009
31
0.080
 Why?
Plasma Exchange
1
2009
25
0.080
 Why?
Vasculitis
1
2008
28
0.070
 Why?
Vincristine
3
2003
88
0.070
 Why?
Transcription Factors
2
2023
566
0.070
 Why?
Syndecan-1
3
2021
73
0.070
 Why?
Biopsy
3
2018
607
0.070
 Why?
DNA Copy Number Variations
2
2021
117
0.070
 Why?
Bone Development
1
2009
66
0.070
 Why?
Drug Therapy, Combination
1
2009
400
0.070
 Why?
Cytogenetics
1
2008
23
0.070
 Why?
Radiopharmaceuticals
2
2021
205
0.070
 Why?
Pain Measurement
1
2009
257
0.070
 Why?
Carrier Proteins
1
2010
320
0.070
 Why?
Platelet Aggregation
1
2008
78
0.070
 Why?
Staphylococcal Infections
2
2019
280
0.070
 Why?
Thrombocytopenia
1
2009
92
0.070
 Why?
Double-Blind Method
1
2009
718
0.070
 Why?
Brain Diseases, Metabolic
1
2007
5
0.070
 Why?
Phlebography
1
2007
55
0.070
 Why?
Hyperammonemia
1
2007
24
0.070
 Why?
Myeloma Proteins
1
2007
26
0.070
 Why?
Antimetabolites
1
2006
12
0.070
 Why?
Chi-Square Distribution
1
2007
295
0.070
 Why?
Cell Communication
2
2023
72
0.070
 Why?
Magnetic Resonance Imaging
4
2007
1545
0.070
 Why?
Partial Thromboplastin Time
1
2006
14
0.060
 Why?
Osteoprotegerin
1
2006
53
0.060
 Why?
Heterozygote
1
2006
91
0.060
 Why?
Acetaminophen
1
2009
279
0.060
 Why?
Antibiotics, Antineoplastic
1
2006
79
0.060
 Why?
Gastrointestinal Neoplasms
1
2006
42
0.060
 Why?
Models, Statistical
1
2007
231
0.060
 Why?
Pilot Projects
1
2008
721
0.060
 Why?
Age Factors
3
2005
1132
0.060
 Why?
Femur Head Necrosis
1
2005
17
0.060
 Why?
Apoptosis
1
2010
1121
0.060
 Why?
Gene Deletion
2
2003
275
0.060
 Why?
Neovascularization, Physiologic
1
2005
87
0.060
 Why?
Syndrome
2
2019
253
0.060
 Why?
ROC Curve
1
2025
254
0.060
 Why?
Ferritins
1
2024
36
0.050
 Why?
Killer Cells, Natural
1
2024
115
0.050
 Why?
Glucuronidase
1
2003
47
0.050
 Why?
Myeloid Progenitor Cells
1
2023
17
0.050
 Why?
X-Ray Microtomography
1
2024
79
0.050
 Why?
CD8-Positive T-Lymphocytes
1
2024
132
0.050
 Why?
Receptors, G-Protein-Coupled
1
2024
57
0.050
 Why?
DNA Methylation
2
2020
592
0.050
 Why?
DNA, Neoplasm
2
2020
146
0.050
 Why?
Antibodies
1
2024
150
0.050
 Why?
Immunosuppressive Agents
1
2005
250
0.050
 Why?
Discitis
1
2003
10
0.050
 Why?
Oligonucleotide Array Sequence Analysis
4
2006
412
0.050
 Why?
Myeloproliferative Disorders
1
2003
31
0.050
 Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
 Why?
Antigens, CD34
1
2003
73
0.050
 Why?
Tumor Cells, Cultured
3
2010
448
0.050
 Why?
Platelet Count
3
2008
76
0.050
 Why?
Rats
1
2009
3203
0.050
 Why?
Patients
1
2022
51
0.050
 Why?
Geography
1
2022
66
0.050
 Why?
Leukemia, Myeloid
1
2002
40
0.050
 Why?
Myeloid Differentiation Factor 88
1
2022
34
0.050
 Why?
Receptors, Antigen, T-Cell
1
2022
51
0.050
 Why?
Drug Interactions
1
2002
205
0.050
 Why?
Chromosome Disorders
1
2002
32
0.050
 Why?
Patient Selection
1
2023
266
0.050
 Why?
United States Food and Drug Administration
1
2022
96
0.050
 Why?
Oncogenes
1
2021
60
0.050
 Why?
Enzyme Inhibitors
1
2004
372
0.050
 Why?
Phylogeny
1
2022
234
0.050
 Why?
Hypothyroidism
1
2002
57
0.050
 Why?
Central Nervous System Neoplasms
1
2002
69
0.040
 Why?
RANK Ligand
1
2022
187
0.040
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
92
0.040
 Why?
Transcriptional Activation
1
2021
128
0.040
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
106
0.040
 Why?
Chromatin
1
2021
141
0.040
 Why?
Cohort Studies
2
2020
1553
0.040
 Why?
Pyrimidines
1
2022
200
0.040
 Why?
Proto-Oncogene Proteins p21(ras)
1
2021
69
0.040
 Why?
Cyclin D2
1
2020
21
0.040
 Why?
Aneuploidy
1
2020
18
0.040
 Why?
Antibodies, Monoclonal, Humanized
1
2022
237
0.040
 Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
 Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
 Why?
Endothelium, Vascular
1
2002
258
0.040
 Why?
ras Proteins
1
2020
64
0.040
 Why?
Histone Code
1
2020
32
0.040
 Why?
Cyclin D1
1
2020
57
0.040
 Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
 Why?
Genome, Human
1
2021
121
0.040
 Why?
Chromosomes, Human, Pair 14
1
2020
75
0.040
 Why?
Longitudinal Studies
2
2016
747
0.040
 Why?
Transcriptional Elongation Factors
1
2020
17
0.040
 Why?
Protein Kinase Inhibitors
1
2022
228
0.040
 Why?
Genetic Loci
1
2020
49
0.040
 Why?
Postoperative Complications
1
2007
1081
0.040
 Why?
DNA Mutational Analysis
1
2020
180
0.040
 Why?
RNA, Messenger
3
2010
1139
0.040
 Why?
Genetic Variation
1
2020
230
0.040
 Why?
Health Status Disparities
1
2022
216
0.040
 Why?
High-Throughput Nucleotide Sequencing
1
2020
179
0.040
 Why?
Neoplastic Stem Cells
2
2015
93
0.040
 Why?
Computational Biology
1
2020
211
0.040
 Why?
Gram-Positive Bacterial Infections
1
2019
30
0.040
 Why?
Pseudomonas Infections
1
2019
54
0.040
 Why?
Proline
1
2018
32
0.040
 Why?
Bone Marrow Cells
2
2014
190
0.040
 Why?
DNA-Binding Proteins
1
2021
426
0.040
 Why?
Fluorescent Dyes
1
2018
91
0.040
 Why?
Recombinant Proteins
2
2010
496
0.040
 Why?
Promoter Regions, Genetic
1
2020
474
0.040
 Why?
Proteolysis
1
2018
102
0.040
 Why?
Receptor Protein-Tyrosine Kinases
1
2018
52
0.040
 Why?
Oncogene Proteins, Fusion
1
2018
60
0.040
 Why?
Extracellular Matrix
1
2018
112
0.040
 Why?
Kidney Function Tests
1
2017
55
0.030
 Why?
False Positive Reactions
1
2017
63
0.030
 Why?
Cell Movement
1
2018
276
0.030
 Why?
Glomerular Filtration Rate
1
2017
130
0.030
 Why?
Amino Acid Sequence
1
2018
574
0.030
 Why?
Genetic Predisposition to Disease
1
2020
528
0.030
 Why?
Cell Survival
2
2010
602
0.030
 Why?
Genes, ras
1
2016
43
0.030
 Why?
Genes, p53
1
2016
52
0.030
 Why?
Mice, SCID
2
2009
182
0.030
 Why?
Glycolysis
1
2016
73
0.030
 Why?
Chromosome Mapping
2
2006
151
0.030
 Why?
Image Interpretation, Computer-Assisted
1
2016
97
0.030
 Why?
Phosphatidylinositol 3-Kinases
1
2016
150
0.030
 Why?
Serum Albumin
2
2008
58
0.030
 Why?
Syndecans
2
2006
37
0.030
 Why?
Proteoglycans
2
2006
87
0.030
 Why?
Cells, Cultured
1
2018
1588
0.030
 Why?
Drug Monitoring
1
2015
83
0.030
 Why?
Interspersed Repetitive Sequences
1
2014
7
0.030
 Why?
Karyotype
1
2014
19
0.030
 Why?
Myocardium
1
2017
479
0.030
 Why?
Proportional Hazards Models
2
2006
444
0.030
 Why?
Membrane Glycoproteins
2
2006
242
0.030
 Why?
Transplantation Chimera
2
2003
16
0.020
 Why?
Neoplasm Staging
2
2007
768
0.020
 Why?
Infusions, Intravenous
2
2003
222
0.020
 Why?
RNA Interference
1
2013
186
0.020
 Why?
Cytomegalovirus
1
2012
30
0.020
 Why?
Viral Load
1
2012
80
0.020
 Why?
Virus Activation
1
2012
39
0.020
 Why?
Graft vs Host Disease
2
2003
88
0.020
 Why?
United States
1
2022
5227
0.020
 Why?
Interferon Regulatory Factor-1
1
2010
14
0.020
 Why?
Cell Growth Processes
1
2010
24
0.020
 Why?
Antiviral Agents
1
2012
177
0.020
 Why?
CDC2-CDC28 Kinases
1
2010
11
0.020
 Why?
Femur
1
2010
133
0.020
 Why?
Long-Term Care
1
2010
51
0.020
 Why?
RNA, Small Interfering
1
2010
218
0.020
 Why?
Peripheral Nervous System Diseases
1
2010
59
0.020
 Why?
Down-Regulation
1
2010
344
0.020
 Why?
Bone Diseases, Metabolic
1
2010
78
0.020
 Why?
Abnormalities, Multiple
1
2010
168
0.020
 Why?
Cell Transformation, Neoplastic
1
2010
184
0.020
 Why?
Protein Isoforms
1
2009
125
0.020
 Why?
Ploidies
1
2008
10
0.020
 Why?
Ligands
1
2009
207
0.020
 Why?
Polyethylene Glycols
1
2008
90
0.020
 Why?
Rabbits
1
2009
373
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
582
0.020
 Why?
Hemoglobins
1
2008
111
0.020
 Why?
Age Distribution
1
2007
175
0.020
 Why?
C-Reactive Protein
1
2008
152
0.020
 Why?
Diagnosis, Differential
1
2010
1048
0.020
 Why?
Mass Screening
1
2010
358
0.020
 Why?
Ammonia
1
2007
86
0.020
 Why?
Multigene Family
1
2006
50
0.020
 Why?
Blood Proteins
1
2007
84
0.020
 Why?
Brain
2
2007
1325
0.020
 Why?
Cyclin D
1
2006
18
0.020
 Why?
Bone Density
1
2009
399
0.020
 Why?
Cyclins
1
2006
38
0.020
 Why?
Evidence-Based Medicine
1
2007
269
0.020
 Why?
RNA, Neoplasm
1
2006
45
0.020
 Why?
Radiography
1
2007
474
0.020
 Why?
Coculture Techniques
1
2006
145
0.020
 Why?
Leukemia, Myeloid, Acute
1
2007
203
0.010
 Why?
Data Interpretation, Statistical
1
2006
164
0.010
 Why?
Neoplasms, Experimental
1
2006
112
0.010
 Why?
Interferon-alpha
1
2005
52
0.010
 Why?
Survivors
1
2006
118
0.010
 Why?
Mice, Transgenic
1
2006
564
0.010
 Why?
Databases, Factual
1
2007
715
0.010
 Why?
Monosomy
1
2003
5
0.010
 Why?
Odds Ratio
1
2005
568
0.010
 Why?
Trisomy
1
2003
35
0.010
 Why?
History, 21st Century
1
2003
59
0.010
 Why?
Endothelial Growth Factors
1
2003
11
0.010
 Why?
Vascular Endothelial Growth Factors
1
2003
15
0.010
 Why?
Lymphokines
1
2003
20
0.010
 Why?
Fusion Proteins, bcr-abl
1
2003
20
0.010
 Why?
History, 20th Century
1
2003
96
0.010
 Why?
Stem Cell Factor
1
2003
7
0.010
 Why?
Lymphocyte Transfusion
1
2003
10
0.010
 Why?
Confidence Intervals
1
2003
159
0.010
 Why?
Interphase
1
2003
10
0.010
 Why?
Probability
1
2003
173
0.010
 Why?
Diploidy
1
2003
25
0.010
 Why?
Leukocyte Count
1
2003
73
0.010
 Why?
Back Pain
1
2003
39
0.010
 Why?
Interferons
1
2002
37
0.010
 Why?
Sex Factors
1
2005
729
0.010
 Why?
Cell Count
1
2003
144
0.010
 Why?
Intercellular Signaling Peptides and Proteins
1
2003
107
0.010
 Why?
Drug Administration Schedule
1
2003
376
0.010
 Why?
Thyroid Function Tests
1
2002
27
0.010
 Why?
Thyrotropin
1
2002
49
0.010
 Why?
Prevalence
1
2005
1017
0.010
 Why?
Fatal Outcome
1
2002
196
0.010
 Why?
Neutrophils
1
2003
148
0.010
 Why?
Tissue Donors
1
2003
126
0.010
 Why?
Cell Division
1
2002
288
0.010
 Why?
Reoperation
1
2003
465
0.010
 Why?
Acute Disease
1
2002
387
0.010
 Why?
Up-Regulation
1
2002
462
0.010
 Why?
Anti-Bacterial Agents
1
2003
803
0.010
 Why?
Zangari's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (496) concept(s)
_
Co-Authors Expand Description
See all (48) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department